AP NEWS
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Eagle Pharmaceuticals to Present at 31st Annual Piper Jaffray Healthcare Conference

November 20, 2019 GMT

WOODCLIFF LAKE, N.J.--(BUSINESS WIRE)--Nov 20, 2019--

Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (“Eagle” or the “Company”) today announced that Scott Tarriff, Chief Executive Officer, and Pete Meyers, Chief Financial Officer, will present at the 31 st Annual Piper Jaffray Healthcare Conference as follows:

 

Date:

Tuesday, December 3, 2019

Time:

11:30 a.m. Eastern Standard Time

Location:

Lotte New York Palace, New York, NY

Webcast:

https://event.webcasts.com/starthere.jsp?ei=1273124&tp_key=d0b36ea10f

The presentation will be webcast live at the aforementioned time, and archived for 30 days thereafter, via the Company’s website at www.eagleus.com, under the Investors + News Section.

About Eagle Pharmaceuticals, Inc.

Eagle is a specialty pharmaceutical company focused on developing and commercializing innovative and differentiated injectable products that address the shortcomings, as identified by physicians, pharmacists and other stakeholders, of existing commercially successful injectable products. Additional information is available on the Company’s website at www.eagleus.com.

View source version on businesswire.com:https://www.businesswire.com/news/home/20191120005269/en/

CONTACT: Investor Relations for Eagle Pharmaceuticals, Inc.:

Lisa M. Wilson

In-Site Communications, Inc.

T: 212-452-2793

E:lwilson@insitecony.com

KEYWORD: UNITED STATES NORTH AMERICA NEW YORK NEW JERSEY

INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL

SOURCE: Eagle Pharmaceuticals, Inc.

Copyright Business Wire 2019.

PUB: 11/20/2019 06:50 AM/DISC: 11/20/2019 06:50 AM

http://www.businesswire.com/news/home/20191120005269/en